StrokeWear: A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life.

StrokeWear：一种新型腕部可穿戴传感器系统，可促进偏瘫上肢在家庭日常生活中的使用。

• 批准号: 10552347
• 负责人: Paolo Bonato
• 金额: $ 100.81万
• 依托单位: BIOSENSICS, LLC
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-08 至 2025-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10552347
• 关键词: Accelerometer; Achievement; Activities of Daily Living; Address; Advanced Development; Affect; Algorithms; Behavior; Behavior Therapy; Behavioral; Bilateral; Chronic; Clinical; Clinical Trials; Collection; Communities; Companions; Computer software; Consultations; Control Groups; Data; Data Storage and Retrieval; Databases; Development; Disasters; Elements; Environment; Feedback; Fostering; Goals; Health Insurance Portability and Accountability Act; Home; Home environment; Hospitals; Human Resources; Impairment; Intervention; Legal patent; Life; Limb structure; Monitor; Motivation; Motor; Motor Activity; Movement; Neuronal Plasticity; Patient Monitoring System; Patients; Pattern; Performance; Phase; Portal System; Randomized Clinical Trials; Recovery; Rehabilitation therapy; Secure; Self Efficacy; Services; Side; Small Business Innovation Research Grant; Stimulus; Stroke; System; Techniques; Technology; Testing; Therapeutic; Time; Training; Upper Extremity; Visit; Work; Wrist; arm; base; behavior change; chronic stroke; commercialization; community setting; design; efficacy testing; experience; flexibility; group intervention; hemiparesis; improved; improved functioning; motor control; motor function recovery; motor recovery; novel; novel strategies; patient engagement; primary endpoint; programs; prototype; remote monitoring; sensor; smartphone Application; stroke survivor; telehealth; treatment as usual; wearable sensor technology; web portal

Abstract Stroke survivors often experience a debilitating loss of motor control typically affecting one side of the body. When performing upper-extremity (UE) movements during activities of daily living (ADLs), stroke survivors naturally favor using the more functional UE, thus leading to restricted use of the hemiparetic UE thereby hindering motor recovery. While therapists use conventional techniques to target the hemiparetic UE during clinical visits, patients receive limited direct training on the use of their hemiparetic UE in their home environment. The lack of therapeutic training in the home environment negatively impacts the recovery of UE motor function. Yet, motor improvements are achievable with sufficient motor practice. Based on this body of evidence, through our completed SBIR Fast-Track study, we developed a patented sensor-based technology, called StrokeWearTM. StrokeWearTM consists of a proprietary software and bilateral wrist-worn sensors to continuously monitor UE movements performed by patients in their home and community environments. The system also generates real- time feedback on the performance of goal directed movements (GDM). The objective of this Phase IIB is to further develop StrokeWearTM for commercialization by enhancing the platform with features that will empower and encourage patients to engage in GDM with their hemiparetic UE in the home and to support expert clinicians to foster increased activity in a telehealth environment. The system promotes behavior changes that optimize UE movement patterns for neuro-recovery. In this project, we will integrate goal setting, self-efficacy, behavioral achievements, and movement feedback into StrokeWearTM. To better engage the users, we will develop a companion smartphone application that will encourage patients to be active in monitoring their progress. Finally, we will develop a web-portal that will allow patients and clinicians to be more engaged and interactive during the rehabilitation program through on-demand goal setting and consultation. We will conduct two 6-month randomized clinical trials to assess the efficacy of this integrated platform in both chronic and subacute stroke survivors. The control group will receive usual care, while the intervention group will receive the StrokeWearTM platform in addition to a motor and behavioral home-based intervention.

摘要